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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
dynamic ankle foot orthotics (DAFO) improve gait in pediatric patients with spastic diplegic 
cerebral palsy (CP). 
 
STUDY DESIGN: Review of two randomized controlled trials with crossover from 2009 and 
2015 and one blinded randomized controlled trial from 2006.  
 
DATA SOURCES: All articles were presented in English and were taken from peer reviewed 
sources using PubMed and Google Scholar. All articles were published between 2006-2016.  
 
OUTCOMES: Outcomes of investigation measured are quantitative walking velocity measured 
via gait analysis and functional ability during ambulation using the Gross Motor Function 
Measurement-88 scoring system.  
 
RESULTS: Wren et al found that there was a statistically significant increase in walking velocity 
while wearing DAFOs when compared to walking barefoot and also with different type of ankle 
foot orthoses. Bjornson et al found statistically significant improvements in the Gross Motor 
Function Measurement-88 scores when wearing DAFOs than when barefoot or wearing a 
simulated placebo device. Smith et al. found overall improvements in gait while wearing DAFOs 
and an increase in velocity after consistent month-long use of DAFOs, but the increase was not 
statistically significant.  
 
CONCLUSIONS: These three studies show that DAFOs provide tangible benefit to individuals 
with spastic diplegic cerebral palsy. All 3 studies showed overall gait or functional 
improvements in those wearing dynamic ankle foot orthotics when compared against either 
themselves or age-matched controls regardless of the length of time the devices were worn with 
2 of the studies showing statistically significant results. Further research can help to further 
clarify the efficacy of DAFOs within the pediatric population as a whole. 
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INTRODUCTION 
 
Cerebral palsy (CP) is an overarching term for a non-progressive group of congenital 
neuromuscular conditions that present with universal themes of muscle hypo/hypertonicity and 
abnormalities in movement and ambulation.1 It is often commonplace to see other symptoms, such 
as cognitive delay, respiratory comorbidities and epilepsy in individuals with CP, but it is not a 
requirement to have those features in order to make a diagnosis of cerebral palsy. One specific 
type of cerebral palsy, spastic diplegic cerebral palsy, contains hypertonicity, spasticity and 
movement challenges that are localized to the lower extremities bilaterally.1 Hypertonic muscles 
in the lower extremities contribute to challenges in ambulation that may impair one’s ability to 
ambulate, overall function and ultimately their quality of life.  
Unfortunately, cerebral palsy is one of the most common congenital birth defects with an 
incidence of 2.11 per 1000 births.2 While there are many types of CP, spastic diplegia is the most 
common.2 Although it is not known exactly what mechanism causes CP, each case does have 
one thing in common: brain injury immediately prior or during delivery that causes an anoxic or 
hypoxic state leading to neuronal injury or death.3  Most individuals with cerebral palsy are born 
premature and subsequently require specialized care within neonatal intensive care units due to 
underdevelopment of critical structures, most commonly their lungs and its ability to produce 
surfactant. Although non-progressive nor terminal, cerebral palsy does require additional 
management throughout a person’s life in order to maintain functionality and quality of life.4 
While the condition as a whole does not progress, symptomatic management is the main focus. 
To achieve this, individuals with cerebral palsy must utilitze healthcare services more frequently 
than the average individual. Data shows that pediatric patients with cerebral palsy visit outpatient 
providers 2.2 times more and are hospitalized 4.3 more often than their able-bodied peers.5 In 
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fact, it is estimated that it costs an extra $80,000 in addition to normal lifetime costs to care for 
someone with cerebral palsy.6 
There are no true diagnostic tests or studies that can diagnose cerebral palsy as a whole. It 
is instead a clinical diagnosis that in the very young can be subtle. It is often not picked up until 
individuals begin to miss age-related milestones that clinicians often suspect cerebral palsy.7 While 
it is often a diagnosis of exclusion, the criteria to classify cerebral palsy are defined and uniform. 
First, the amount of resting muscle tone that an individual has is evaluated to be either spastic 
(hypertonic) or non-spastic (hypotonic).7 For spastic individuals, the body region affected is then 
classified (diplegia, hemiplegia, or quadriplegia).7 Individuals with non-spastic CP are broken 
down by whether their movements are voluntary, involuntary or involve their whole body (ataxia, 
dyskinetic or athenoid).7 
Much like there being no true diagnosis of CP of any type, there is no definitive treatment. 
Instead this condition is treated solely symptomatically. By definition, spastic diplegic CP contains 
hypertonic muscles (spastic) and affects the lower extremities bilaterally (diplegic) with little to 
no involvement in the upper extremities. There are many different modalities employed to limit or 
decrease one’s tone and improve overall function all with varying successes. While each treatment 
is tailored to the severity of one’s spasticity, there are many types of standard treatments that can 
be done for a patient ranging from physical therapy to stretching and strengthening, assistive 
devices (crutches, wheelchairs, orthotics), medications to reduce spasms, and various types of 
orthopedic surgery.4 Of all the treatments, one of the least invasive and most commonly employed 
is the use of ankle foot orthotics. The orthotics are custom fitted to the patient and provide a 
continuous stretch of specific muscle groups, while providing support.8 There are many different 
variations of these orthotics that a clinician can prescribe for a patient to serve individual needs 
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depending on their specific gait and muscle tone. Ankle foot orthotics can range from flexible 
(dynamic), solid, adjustable or hinged at the talocalcaneal joint.8,9 One orthotic type used is a 
dynamic ankle foot orthotic (DAFO), a non-hinged single piece flexible brace that provides 
support at the malleoli, while still allowing a patient to ambulate through a full gait cycle.9 
Dynamic ankle foot orthotics serve as a noninvasive way to augment other long term modalities 
(i.e. surgery) in improving patient’s walking speed and ambulatory function. 
OBJECTIVE: 
 The objective of this selective EBM review is to determine whether or not dynamic ankle 
foot orthotics (DAFO) improve gait in pediatric patients with spastic diplegic cerebral palsy (CP).  
METHODS:  
Two randomized controlled trials with a crossover and a blinded randomized controlled 
trial were chosen for review.  The patient population selected for review was ambulatory patients 
under the age of 18 years old with a diagnosis of spastic diplegic cerebral palsy. Interventions 
employed included use of dynamic ankle foot orthotics bilaterally. Depending on the study, 
subjects were either aged matched to controls or to themselves with appropriate washout periods. 
Outcomes measured were patient oriented and focused on: ambulatory velocity and functional 
changes in ambulation using the Gross Motor Function Measurement-88 objective scoring system.  
Both Google Scholar and PubMed databases were utilized to select studies. Keywords used 
to search were “cerebral palsy” and “dynamic ankle foot orthotics.” The three studies selected 
were published in peer reviewed journals between 2006-2016 and all were written in English. In 
general, inclusion criteria for all three studies was the same: ambulatory pediatric patients under 
18 years old with a primary diagnosis of spastic diplegic cerebral palsy. Two of the three studies 
provided the same exclusion criteria, subjects over 18 years of age and/or those that have 
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undergone an orthopedic/neurosurgical or botulinum toxin A injection within 12 or 6 months of 
participation, respectively. Detailed inclusion and exclusion criteria, as well as other individual 
study characteristics, are provided in Table 1. The statistics reported in the studies and utilized for 
the review were p-values, X2 and ANOVA. 
Table 1. - Demographics & characteristics of included studies  
Study Type # Pts Age 
(yrs.) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/
D 
Interventions 
Smith 
(2009)9 
RCT with 
Crossover 
15 
subjects 
 
20 
controls 
 
Mean 
age: 7.5 ± 
2.9 years  
 
(Age 
range not 
disclosed) 
 
-Age: ≤13 years 
-Ambulate 
without assistive 
devices 
(crutches/cane 
etc.) 
- “Jump gait” 
pattern of walking  
-Baseline 
GMFCS-88 
Score: 1  
-Ability to 
dorsiflex ankle to 
neural position on 
PE 
 
1. Any 
orthopedic or 
neurological 
surgical 
intervention 
within 12 
months  
2. Botulism 
toxin A 
injections 
within 6 
months 
0 Daily use of 
dynamic or 
hinge ankle foot 
orthotic for 4 
weeks. Washout 
period of 2 
weeks. Daily 
use of other 
ankle foot 
orthotic for 4 
weeks  
 
Wren 
(2015)10 
RCT with 
Crossover 
10 
subjects 
Ages:  
4-12 
years old 
-Age: 0-18 years 
old -Crouch 
and/or equinus 
gait  
-Baseline 
GMFCS-88 Level 
I—III 
None 
provided 
0 Wearing 
dynamic ankle 
foot orthotics 
daily for 4 
weeks, then 
wearing ADR-
AFOs for 
another 4 weeks 
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OUTCOMES MEASURED:  
This review examined both ambulatory velocity and changes in Gross Motor Function 
Measurement – 88 (GMFCS-88) scores when using DAFOs bilaterally. Using a motion analysis 
program to track, measure and video record body motion while ambulating, velocity was 
calculated both with and without a DAFO. To measure GMFCS-88 scores, a licensed pediatric 
physical therapist scored patients both with and without the device. This objective scoring system 
scores patients by ability and ease to do a variety of specific functional motions (rolling, sitting, 
crawling, kneeling, standing, walking, running and jumping).  
RESULTS:  
Smith et al., conducted a randomized controlled trial age matched comparing 15 subjects 
and 20 age matched controls that were 13 years of age or younger who did not use any assistive 
devices to ambulate on a daily basis.9 The authors reported a mean age of 7.5 ± 2.9 years of age. 
Additional inclusion and exclusion criteria are provided in Table 1. This trial examined ambulatory 
velocity of individuals after using DAFOs daily for 4 weeks, which allowed the participants time 
to adjust and become accustomed to the device. 9 Velocity was measured via motion analysis three 
Bjornson 
(2006)11 
RCT with 
Crossover 
& Double 
Blinding   
 
23 
subjects 
Ages: 
1.9-7.3 
years old 
-Age: 12-96 
months  
 -GMFCS-88 
levels 1-3  
-Current use of 
bilateral dynamic 
foot orthotic with 
free 
plantarflexion  
-Minimum 
orthotic use of 4 
hours per day for 
at least one month 
 
1.Orthopedic 
or 
neurological 
surgical 
intervention 
within 12 
months  
2. Botulism 
toxin A 
injections 
within 6 
months 
0 Wearing sock 
covered DAFOs 
and undergoing 
GMFM scoring 
2x and then 
repeating test 
with placebo 
(sock cover 
mimicking 
DAFO) 
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times at the end of the 4 weeks while the participant wore DAFOs bilaterally and compared to 
patient’s barefoot baseline and also while wearing another ankle foot orthotics after a 2-week 
washout period. The order in which a participant wore a DAFO or the other type of ankle foot 
orthotic included in the study was randomized. There was a 0% loss to follow up at the conclusion 
of the research.9 The researchers used continuous data, which is provided in Table 2. The results 
of this study show that patient’s ambulatory velocity minimally increased if one was wearing a 
dynamic foot orthotic or if they were barefoot. Using ANOVA, examiners found that there were 
no statistically significant changes in ambulatory velocity when comparing the DAFO and barefoot 
conditions using a P ≤ 006 as being statistically significant but did not provide individual P-values.9  
Table 2. – Ambulatory Velocity (m/s) at baseline and with DAFO use 
Condition: Mean and Standard Deviation 
Baseline (Barefoot) 1.01 ± 0.6 
DAFO 1.11 ± 0.6 
Mean Change in Velocity 0.10 ± 0.0 (P ≤ 006) 
 
Wren et al. directed a randomized controlled trial with crossover that looked at ambulatory 
velocity of 10 children (40% male, 60% female) between 4-12 years old with differing baseline 
GMFCS-88 scores against age matched controls while wearing custom fitted DAFOs, other 
custom fitted orthotics and barefoot.10 Both orthotic types were worn for 4 weeks without a 
washout period. As is shown in Table 1, the inclusion criteria included baseline gross motor 
function scores of I-III and either a crouch or equinus pattern gait.10 The distribution of GMFCS-
88 baseline classifications is shown in Table 3. 4 of the subjects who were classified as GMFCS-
88 level III and used assistive devices as their baseline and were permitted to use them during the 
testing. 10 There was 0% loss to follow up throughout the trial and participants reported no adverse 
effects. The data was reported as continuous and is shown in Table 4. This research shows that 
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there was a statistically significant increase (P = .006; CI: 95%) in ambulatory velocity when using 
DAFOs than when compared to their barefoot baseline.  
Table 3: Number of Participants based on GMFCS-88  
Baseline Gross Motor 
Function Classification Score 
I II III 
Classification Level 
Interpretation11 
Walks without 
restrictions; some 
limitations with 
running/jumping 
Walks with 
assistance from 
surrounding and 
/or crutches 
Walks with 
assistance of 
walker and/or 
crutches 
Number of Participants 6 0 4 
 
Table 4: Mean Ambulatory Velocity (m/s) 
 Barefoot (Mean ± SD) DAFO (Mean ± SD) Mean Change 
Velocity (m/s) 0.72 ± 0.34 0.78 ± 0.34 0.06 ± 0.00 
Statistical Measures   P =.006 (CI: 95%) 
 
Using a double blinded randomized controlled trial, Bjornson et al examined 23 
participants with differing GMFCS-88 score baselines to evaluate any changes in GMFCS-88 
scores when barefoot and while wearing bilateral DAFOs.12 Each participant had used bilateral 
DAFO daily prior to participation in the research. DAFOs or placebo orthotics were applied to the 
participant and covered with athletic wear to allow for blinding from a physical therapist scoring 
each participant.12 Subjects ranged from 1.9 –7.3 years of age. Each participant was scored on 3 
different activity categories using the GMFCS-88 scoring system: crawling/kneeling, standing, 
and walking/running/jumping. Each category contains a certain number of specific tasks and 
movements that patients are asked to complete. Continuous data was collected and the results of 
the “walking/running/jumping” category are shown in Table 5. 12 This research shows that there 
was an increase in the participants’ level of function in terms of running, jumping and walking. 
The p-value and chi squared calculation demonstrate that the increase is statistically significant 
and that participants demonstrating higher scores on the GMFCS-88 are not due to chance, but 
instead due to an association between the intervention (DAFO use) and ambulation. 
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Table 5: Average GMFCS-88 Scores for Walking/Running/Jumping 
Condition (Mean ± SD) 
Barefoot  19.9 ± 17.7 
DAFO 26.4 ± 23.6 
Difference (DAFO – Barefoot) 6.5 ± 5.9  
P- Value:   <.001 
X2  6.7 
  
Unlike other medical treatments, in which treatments are invasive or absorbed via a 
medication, dynamic ankle foot orthotics are noninvasive and external. Their effects are immediate 
and the effectiveness is dependent on wearing the devices. As a result, none of the reviewed studies 
reported any adverse effects or safety concerns. 
DISCUSSION:  
The content of this evidence based systematic review focused on if dynamic ankle foot 
orthotics affect ambulatory function and speed of pediatric patients with spastic diplegic pattern 
cerebral palsy. Orthotics, as a whole, are considered exempt from regulation by the Food and Drug 
Administration.13 Instead, indications for the appliances originate directly from insurance 
companies. Generally, dynamic foot orthotics are indicated for individuals with a plantar flexion 
spasticity and contracture upon passive dorsiflexion.14 From the perspective of cerebral palsy, 
DAFOs are indicated in ambulatory individuals who require ankle support due to weak dorsiflexor 
muscles, but are able to plantarflex without assistance.8 There are no absolute contraindications 
for the use of dynamic ankle foot orthotics as they will not cause harm to a patient, but they are 
ineffective in certain cases, such as individuals with a “foot drop” that do not have ankle 
contractures.13 
 Through researching the topic, there were a few study limitations that could have impacted 
the review. One limitation revolved around the fact that there are many types of ankle foot orthotics 
making selection of studies that met all criteria challenging. Additionally, each of the studies 
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chosen had small sample sizes and none of them utilized patients between 14-18 years of age, 
which would still be considered pediatric patients. As the age ranges of the selected studies 
examined young children through adolescents, it may be difficult to generalize the results towards 
teenagers. Larger sample sizes with a wider age range would provide more evidence about the 
effects or lack thereof of DAFOs on ambulation in the pediatric spastic diplegic cerebral palsy 
population.  
CONCLUSION:  
As a whole, the evidence shows that dynamic ankle foot orthotics have a positive impact 
on ambulation velocity and functional ability in pediatric patients with spastic diplegic cerebral 
palsy but further research is necessary to confirm the relationship. Both of the studies examining 
ambulation velocity showed increases when wearing the orthoses, but only one study showed a 
statistically significant increase.9,11 Smith et al, only used participants with a Gross Motor Function 
Classification Score of I, which may have influenced the outcomes as these participants are the 
highest functioning and may not benefit from the devices.9  Bjornson et al, proved a statistically 
significant increase in the Gross Motor Function Classification System-88 score for the 
walking/running/jumping category.12 While this is only one study showing significant 
improvements in functional scoring, it is important for future research to be completed to further 
validate this increase in ambulatory function. Additionally, it is important to examine more age 
groups (older adolescents and young adults) to determine whether the effects are as profound as 
they are in the young pediatric population. 
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